Annual Current Liabilities
$10.19 M
+$2.01 M+24.51%
December 1, 2023
Summary
- As of February 12, 2025, ZVSA annual total current liabilities is $10.19 million, with the most recent change of +$2.01 million (+24.51%) on December 1, 2023.
- During the last 3 years, ZVSA annual current liabilities has risen by +$2.64 million (+34.92%).
- ZVSA annual current liabilities is now -25.18% below its all-time high of $13.63 million, reached on December 31, 2021.
Performance
ZVSA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$11.54 M
+$1.55 M+15.48%
September 1, 2024
Summary
- As of February 12, 2025, ZVSA quarterly total current liabilities is $11.54 million, with the most recent change of +$1.55 million (+15.48%) on September 1, 2024.
- Over the past year, ZVSA quarterly current liabilities has increased by +$1.96 million (+20.45%).
- ZVSA quarterly current liabilities is now -32.73% below its all-time high of $17.16 million, reached on June 1, 2022.
Performance
ZVSA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ZVSA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.5% | +20.4% |
| 3 y3 years | +34.9% | -32.7% |
| 5 y5 years | +34.9% | -32.7% |
ZVSA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.2% | +24.5% | -32.7% | +41.0% |
| 5 y | 5-year | -25.2% | +34.9% | -32.7% | +41.0% |
| alltime | all time | -25.2% | +34.9% | -32.7% | +41.0% |
ZyVersa Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.54 M(+15.5%) |
| Jun 2024 | - | $9.99 M(+4.3%) |
| Mar 2024 | - | $9.58 M(-6.0%) |
| Dec 2023 | $10.19 M | $10.19 M(-12.9%) |
| Sep 2023 | - | $11.71 M(+11.7%) |
| Jun 2023 | - | $10.48 M(+22.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $8.58 M(+4.8%) |
| Dec 2022 | $8.19 M(-39.9%) | $8.19 M(-42.1%) |
| Sep 2022 | - | $14.15 M(-17.5%) |
| Jun 2022 | - | $17.16 M(+25.9%) |
| Dec 2021 | $13.63 M(+80.3%) | - |
| Dec 2021 | - | $13.63 M |
| Dec 2020 | $7.56 M | - |
FAQ
- What is ZyVersa Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics annual current liabilities year-on-year change?
- What is ZyVersa Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ZyVersa Therapeutics?
- What is ZyVersa Therapeutics quarterly current liabilities year-on-year change?
What is ZyVersa Therapeutics annual total current liabilities?
The current annual current liabilities of ZVSA is $10.19 M
What is the all time high annual current liabilities for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high annual total current liabilities is $13.63 M
What is ZyVersa Therapeutics annual current liabilities year-on-year change?
Over the past year, ZVSA annual total current liabilities has changed by +$2.01 M (+24.51%)
What is ZyVersa Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ZVSA is $11.54 M
What is the all time high quarterly current liabilities for ZyVersa Therapeutics?
ZyVersa Therapeutics all-time high quarterly total current liabilities is $17.16 M
What is ZyVersa Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ZVSA quarterly total current liabilities has changed by +$1.96 M (+20.45%)